BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 10194125)

  • 1. Lymphomas in patients with Sjögren's syndrome: review of the literature and physiopathologic hypothesis.
    Mariette X
    Leuk Lymphoma; 1999 Mar; 33(1-2):93-9. PubMed ID: 10194125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells.
    Mariette X
    Ann Rheum Dis; 2001 Nov; 60(11):1007-10. PubMed ID: 11602464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphomas in patients with Sjogren's syndrome are marginal zone B-cell neoplasms, arise in diverse extranodal and nodal sites, and are not associated with viruses.
    Royer B; Cazals-Hatem D; Sibilia J; Agbalika F; Cayuela JM; Soussi T; Maloisel F; Clauvel JP; Brouet JC; Mariette X
    Blood; 1997 Jul; 90(2):766-75. PubMed ID: 9226177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lymphoproliferative disorders in Sjögren's syndrome].
    Prochorec-Sobieszek M; Wagner T
    Otolaryngol Pol; 2005; 59(4):559-64. PubMed ID: 16273862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salivary gland B cell lymphoproliferative disorders in Sjögren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas.
    De Re V; De Vita S; Gasparotto D; Marzotto A; Carbone A; Ferraccioli G; Boiocchi M
    Eur J Immunol; 2002 Mar; 32(3):903-10. PubMed ID: 11870635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salivary gland lymphomas in patients with Sjögren's syndrome may frequently develop from rheumatoid factor B cells.
    Martin T; Weber JC; Levallois H; Labouret N; Soley A; Koenig S; Korganow AS; Pasquali JL
    Arthritis Rheum; 2000 Apr; 43(4):908-16. PubMed ID: 10765938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant lymphoma in primary Sjögren's syndrome: an update on the pathogenesis and treatment.
    Routsias JG; Goules JD; Charalampakis G; Tzima S; Papageorgiou A; Voulgarelis M
    Semin Arthritis Rheum; 2013 Oct; 43(2):178-86. PubMed ID: 23816048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological factors relating malignant lymphoma with Sjögren's syndrome.
    Anaya JM; McGuff HS; Banks PM; Talal N
    Semin Arthritis Rheum; 1996 Apr; 25(5):337-46. PubMed ID: 8778989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotypic rheumatoid factors that are frequently expressed in mucosa-associated lymphoid tissue-type lymphomas are rare in the labial salivary glands of patients with Sjögren's syndrome.
    Bende RJ; Slot LM; Hoogeboom R; Wormhoudt TA; Adeoye AO; Guikema JE; van Noesel CJ
    Arthritis Rheumatol; 2015 Apr; 67(4):1074-83. PubMed ID: 25546553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of B cell lymphoma in patients with Sjögren's syndrome and hepatitis C virus infection.
    Ramos-Casals M; la Civita L; de Vita S; Solans R; Luppi M; Medina F; Caramaschi P; Fadda P; de Marchi G; Lopez-Guillermo A; Font J;
    Arthritis Rheum; 2007 Feb; 57(1):161-70. PubMed ID: 17266090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin's lymphomas complicating Sjögren's syndrome: can Epstein Barr virus be implicated?
    Jeffers M; Crilly A; Kerr T; Richmond J; Madhok R
    Scand J Rheumatol; 1997; 26(3):180-3. PubMed ID: 9225872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Gougerot-Sjögren syndrome. Risk of lymphoma].
    Mariette X
    Presse Med; 1999 Jun; 28(22):1214-8. PubMed ID: 10414252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary tumours in Sjögren's syndrome.
    Kovács L; Szodoray P; Kiss E
    Autoimmun Rev; 2010 Feb; 9(4):203-6. PubMed ID: 19602455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy.
    De Vita S; Quartuccio L; Salvin S; Corazza L; Zabotti A; Fabris M
    Rheumatology (Oxford); 2012 Apr; 51(4):627-33. PubMed ID: 22210656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sjögren's syndrome and non-Hodgkin's lymphoma: from pathophysiology to treatment].
    Le Guern V; Mouthon L
    Presse Med; 2011 Dec; 40(12 Pt 1):1113-9. PubMed ID: 21964038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactivation of Epstein-Barr virus in Sjögren's syndrome.
    Fox RI; Luppi M; Kang HI; Pisa P
    Springer Semin Immunopathol; 1991; 13(2):217-31. PubMed ID: 1664987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gougerot-Sjögren syndrome and malignant lymphoproliferative syndromes].
    Grosbois B; Jego P; Leblay R
    Rev Med Interne; 1998 May; 19(5):319-24. PubMed ID: 9775165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoproliferative disease in SCID mice reconstituted with human Sjögren's syndrome lymphocytes.
    Fox RI; Pisa P; Pisa EK; Kang HI
    J Clin Lab Anal; 1993; 7(1):46-56. PubMed ID: 8381174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low miR200b-5p levels in minor salivary glands: a novel molecular marker predicting lymphoma development in patients with Sjögren's syndrome.
    Kapsogeorgou EK; Papageorgiou A; Protogerou AD; Voulgarelis M; Tzioufas AG
    Ann Rheum Dis; 2018 Aug; 77(8):1200-1207. PubMed ID: 29779010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome.
    Sugai S; Shimizu S; Tachibana J; Imaoka S; Konda S
    J Autoimmun; 1989 Aug; 2(4):471-6. PubMed ID: 2506879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.